聚合酵素链锁反应(PCR)系统的全球市场 - 市场规模(各市场区隔)，占有率，法规，偿付，预测(～2033年)

本报告提供全球聚合酵素链锁反应(PCR)系统市场相关调查分析，提供主要企业与市场占有率，主要趋势，创新的产品与技术，竞争情形等资讯。

市场模式的主要内容如下列。

已上市的聚合酵素链锁反应(PCR)系统与不断变化的竞争格局

• 主要的产业趋势考察
• 按聚合酵素链锁反应(PCR)系统市场区隔的年度收益与市场预测(2015年～2033年)
• 台数，平均销售价格，市场金额相关市场层级的资料

世界，地区，国家层级的市场固有考察

• 各地区分类的全球趋势之特定市场定性资讯和国家/地区考察
• 聚合酵素链锁反应(PCR)系统市场SWOT分析
• 聚合酵素链锁反应(PCR)系统市场竞争动态的考察和趋势

透过对医疗保健系统的真实、全面的了解来促进市场了解。市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规形势

对象企业

• Cepheid Inc
• Bio-Rad Laboratories Inc
• Thermo Fisher Scientific Inc
• Qiagen NV
• Abbott Laboratories
• bioMerieux Inc
• Becton Dickinson and Co
• Siemens Healthineers AG
• Roche Diagnostics International Ltd
• Standard BioTools Inc
• Hologic Inc
• 其他

Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

The Polymerase chain reaction (PCR) is a method used to amplify and analyze short DNA (or RNA) sequences in a sample with small quantities of RNA or DNA, through repeated heating and cooling of nucleic acids, combined with recombinant enzymes, to mimic the natural process used in cells to repair DNA. PCR amplifies the selected sequence of DNA segments producing millions of copies within a few hours. Quantitative PCR (qPCR) is a modification of the technique that allows measurement of the amplified RNA or DNA.

Polymerase Chain Reaction (PCR) Systems are instruments used to perform nucleic acid amplification, typically in support of investigations concerning the diagnosis or prognosis of cancer or infectious disease. The Polymerase Chain Reaction (PCR) System tracks the essential equipment only, and not accessories and/or additional costs associated with PCR System installation.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Polymerase Chain Reaction (PCR) Systems and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Polymerase Chain Reaction (PCR) Systems market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Polymerase Chain Reaction (PCR) Systems market.
• Competitive dynamics insights and trends provided for Polymerase Chain Reaction (PCR) Systems market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Cepheid Inc, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Qiagen NV, Abbott Laboratories, bioMerieux Inc, Becton Dickinson and Co, Siemens Healthineers AG, Roche Diagnostics International Ltd, Standard BioTools Inc, Hologic Inc, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the PCR Systems market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Polymerase Chain Reaction (PCR) Systems market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Polymerase Chain Reaction (PCR) Systems market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Polymerase Chain Reaction (PCR) Systems market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.